Zarrabi, Kevin
Paroya, Azzam
Wu, Shenhong
Article History
Received: 15 June 2019
Accepted: 21 August 2019
First Online: 4 September 2019
Ethics approval and consent to participate
: Not applicable.
: Not applicable.
: S. Wu is a speaker for Exelixis, Novartis, and Pfizer. The other authors declare that they have no competing interests.